Improved outcome of Henoch-Schonlein purpura nephritis by early intensive treatment

Indian Journal of Pediatrics

Volumn 79, Issue 2, 2012, Pages 207-212

  Deng, Fang ^a   Lu, Ling ^a   Zhang, Qin ^a   Hu, Bo ^a   Xia, Xun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Childhood; Henoch Sch nlein purpura; Nephritis; Therapy

Indexed keywords

CREATININE; GLYCOSIDE; HYDROCORTISONE SODIUM SUCCINATE; METHYLPREDNISOLONE; STEROID; TRIPTERYGIUM GLYCOSIDE; UNCLASSIFIED DRUG; UREA;

ANAPHYLACTOID PURPURA; ARTICLE; BLOOD PRESSURE; CHILD; CREATININE BLOOD LEVEL; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; HEMATURIA; HENOCH SCHONLEIN PURPURA NEPHRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; PROTEINURIA; RETROSPECTIVE STUDY; UREA BLOOD LEVEL; URINALYSIS; HOSPITALIZATION; TREATMENT OUTCOME;

CHILD; FEMALE; HUMANS; MALE; NEPHRITIS; PURPURA, SCHOENLEIN-HENOCH; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84861497180     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-011-0519-5     Document Type: Article

References (23)

1. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197-202. (Pubitemid 35232718)
2. Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatr. 1988;147:113-5. (Pubitemid 18081989)
3. Tarshish P, Bernstein J, Edelmann Jr CM. Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol. 2004;19:51-6. (Pubitemid 38088250)
4. Butani L, Morgenstern BZ. Long-term outcome in children after Henoch-Schonlein purpura nephritis. Clin Pediatr (Phila). 2007;46:505-11. (Pubitemid 46920338)
5. Edström Halling S, Söderberg MP, Berg UB. Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience. Pediatr Nephrol. 2009;24:91-7.
6. Foster BJ, Bernard C, Drummond KN, Sharma AK. Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histophatologic study. J Pediatr. 2000;136:370-5. (Pubitemid 30470961)
7. Flynn JT, Smoyer WE, Bunchman TE, Kershaw DB, Sedman AB. Treatment of Henoch-Schonlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol. 2001;21:128-33. (Pubitemid 32453691)
8. Ronkainen J, Autio-Harmainen H, Nuutinen M. Cyclosporin A for the treatment of severe Henoch-Schonlein glomerulonephritis. Pediatr Nephrol. 2003;18:1138-42. (Pubitemid 37406861)
9. Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N. Multiple combined therapy for severe Henoch-Schonlein nephritis in children. Pediatr Nephrol. 1998;12:244-8. (Pubitemid 28204134)
10. Shenoy M, Ognjanovic MV, Coulthard MG. Treating severe Henoch-Schonlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol. 2007;22:1167-71.
11. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936-41.
12. Ronkainen J, Koskimies O, Ala-Houhala M, et al. Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2006;149:241-7. (Pubitemid 44144490)
13. Lau KK, Suzuki H, Novak J, Wyatt RJ. Pathogenesis of Henoch- Schönlein purpura nephritis. Pediatr Nephrol. 2010;25:19-26.
14. Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol. 1998;12:238-43. (Pubitemid 28204133)
15. Shin JI, Park JM, Shin YH, et al. Can azathioprine and steroids alter the progression of severe Henoch-Schönlein nephritis in children? Pediatr Nephrol. 2005;20:1087-92. (Pubitemid 41001547)
16. Shenoy M, Bradbury MG, Lewis MA, Webb NJ. Outcome of Henoch- Schönlein purpura nephritis treated with longterm immunosuppression. Pediatr Nephrol. 2007;22:1717-22. (Pubitemid 47337426)
17. Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S. Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol. 2003;18:347-50. (Pubitemid 36790072)
18. Zheng CX, Chen ZH, Zeng CH, Qin WS, Li LS, Liu ZH. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro. Kidney Int. 2008;74:596-612.
19. Wan Y, Sun W, Zhang H, et al. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates prolonged mesangial lesions in experimental progressive glomerulonephritis. Nephron Exp Nephrol. 2010;114:e7-14.
20. Wan Y, Gu L, Suzuki K, et al. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody. Nephron Exp Nephrol. 2005;99:e121-9.
21. Sharma M, Li JZ, Sharma R, et al. Inhibitory effect of Tripterygium wilfordii multiglycoside on increased glomerular albumin permeability in vitro. Nephrol Dial Transplant. 1997;12:2064-8. (Pubitemid 27423242)
22. Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum. 2005;35:143-53. (Pubitemid 41713954)
23. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Sehsnlein purpura:a retrospective cohort study. Lancet. 2002;360:666-70. (Pubitemid 35232334)